SynapCon is scaling the digital infrastructure layer for global medical research.

​

Our cloud-native platform supports the full regulated research lifecycle — from preclinical frameworks to clinical execution, regulatory submission, and AI-enabled compliance automation.

​

Mission-critical research infrastructure.
Delivered via scalable subscription model.

​

• International expansion
   

• Strong partner network
   

• Recurring subscription-based infrastructure revenues
   

• Regulatory-grade architecture
   

• AI-enabled product expansion roadmap
   

• Recipient of €1.45M German R&D tax credit under FZulG for a €5.8M approved

       development programme.
 

• Positioned for disciplined, scalable expansion.

​

Important Investment Notice

​

​Equity investments involve significant risk, including possible loss of capital. This page does not constitute an offer of securities. Investments are made solely via the official investment platform and at the investor’s own responsibility.

​

Choose Your Investment Path:​

​